Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1979 Mar;55(641):180–187. doi: 10.1136/pgmj.55.641.180

Bile acid, neutral sterol and faecal fat excretion in subjects treated with fenfluramine and its relationship to fenfluramine-induced diarrhoea.

M S Sian, A J Rains
PMCID: PMC2425397  PMID: 461280

Abstract

Bile acid, neutral sterol and faecal fat excretion was studied over a period of 9 weeks in a group of 16 healthy subjects before, during and after administration of fenfluramine. Statistical analysis revealed a significant increase in bile acid excretion during the drug phase (P less than 0.02); and during recovery period of 3 weeks (P less than 0.05). Faecal neutral sterol, as the total of coprostanol and cholesterol elimination was also enhanced after fenfluramine. Coprostanol was replaced by cholesterol in 12 subjects. Faecal fat was studied in 6 subjects, the excretion increased during the drug phase (P less than 0.05), and remained elevated during the post-drug period (P less than 0.01). The composition of the bile acids remained unaltered in all the subjects except 3 who had a fenfluramine-induced watery diarrhoea; and these excreted chenodeoxy and cholic together with smaller amounts of secondary bile acids. A higher excretion of bile acids was found in the 8 overweight subjects (P less than 0.01) before ministration of fenfluramine. These results are discussed in an attempt to correlate the effect of fenfluramine with changes in bile acid and neutral sterol excretion, and its relationship to fenfluramine-induced diarrhoea.

Full text

PDF
180

Images in this article

185Fig. 4
on p.185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aries V. C., Crowther J. S., Drasar B. S., Hill M. J., Ellis F. R. The effect of a strict vegetarian diet on the faecal flora and faecal steroid concentration. J Pathol. 1971 Jan;103(1):54–56. doi: 10.1002/path.1711030108. [DOI] [PubMed] [Google Scholar]
  2. Bliss B. P., Kirk C. J., Newall R. G. The effect of fenfluramine on glucose tolerance, insulin, lipid and lipoprotein levels in patients with peripheral arterial disease. Postgrad Med J. 1972 Jul;48(561):409–413. doi: 10.1136/pgmj.48.561.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ENEROTH P., HELLSTROEM K., RYHAGE R. IDENTIFICATION AND QUANTIFICATION OF NEUTRAL FECAL STEROIDS BY GAS-LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY: STUDIES OF HUMAN EXCRETION DURING TWO DIETARY REGIMENS. J Lipid Res. 1964 Apr;5:245–262. [PubMed] [Google Scholar]
  4. Eneroth P., Hellström K., Sjövall J. A method for quantitative determination of bile acids in human feces. Bile acids and steroids 195. Acta Chem Scand. 1968;22(6):1729–1744. doi: 10.3891/acta.chem.scand.22-1729. [DOI] [PubMed] [Google Scholar]
  5. Evans E., Miller D. S., Samuel P. D., Burland W. L. The effects of fenfluramine and 780SE on fat absorption. Postgrad Med J. 1975;51 (Suppl 1):115–116. [PubMed] [Google Scholar]
  6. Evrard E., Janssen G. Gas-liquid chromatographic determination of human fecal bile acids. J Lipid Res. 1968 Mar;9(2):226–236. [PubMed] [Google Scholar]
  7. Hill M. J., Drasar B. S. Degradation of bile salts by human intestinal bacteria. Gut. 1968 Feb;9(1):22–27. doi: 10.1136/gut.9.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hollingsworth D. R., Amatruda T. T., Jr Toxic and therapeutic effects of EMTP in obesity. Clin Pharmacol Ther. 1969 Jul-Aug;10(4):540–542. doi: 10.1002/cpt1969104540. [DOI] [PubMed] [Google Scholar]
  9. Huang C. T., Nichols B. L. New solvent systems for the separation of free and conjugated bile acids. II. Separation of free bile acids as a group. J Chromatogr. 1975 Jun 18;109(2):427–431. doi: 10.1016/s0021-9673(01)91822-9. [DOI] [PubMed] [Google Scholar]
  10. Kirwan W. O., Smith A. N., Mitchell W. D., Falconer J. D., Eastwood M. A. Bile acids and colonic motility in the rabbit and the human. Gut. 1975 Nov;16(11):894–902. doi: 10.1136/gut.16.11.894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Meihoff W. E., Kern F., Jr Bile salt malabsorption in regional ileitis, ileal resection and mannitol-induced diarrhea. J Clin Invest. 1968 Feb;47(2):261–267. doi: 10.1172/JCI105722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mekjian H. S., Phillips S. F., Hofmann A. F. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest. 1971 Aug;50(8):1569–1577. doi: 10.1172/JCI106644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Miettinen T. A. Cholesterol production in obesity. Circulation. 1971 Nov;44(5):842–850. doi: 10.1161/01.cir.44.5.842. [DOI] [PubMed] [Google Scholar]
  14. Mitchell W. D., Eastwood M. A. Faecal bile acids and neutral steroids in patients with ileal dysfunction. Scand J Gastroenterol. 1972;7(1):29–32. doi: 10.3109/00365527209180734. [DOI] [PubMed] [Google Scholar]
  15. Nestel P. J., Hunter J. D. Differences in bile acid excretion in subjects with hypercholesterolaemia, hypertriglyceridaemia and overweight. Aust N Z J Med. 1974 Oct;4(5):491–496. doi: 10.1111/j.1445-5994.1974.tb03223.x. [DOI] [PubMed] [Google Scholar]
  16. Pawan G. L. Effect of fenfluramine on blood-lipids in man. Lancet. 1969 Mar 8;1(7593):498–500. doi: 10.1016/s0140-6736(69)91594-3. [DOI] [PubMed] [Google Scholar]
  17. Rubulis A., Rubert M., Faloon W. W. Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine. Am J Clin Nutr. 1970 Sep;23(9):1251–1259. doi: 10.1093/ajcn/23.9.1251. [DOI] [PubMed] [Google Scholar]
  18. Tomlinson S. A., Lines J. G., Greenfield M. A. The effect of fenfluramine on obesity and plasma lipids of patients with renal allografts. Postgrad Med J. 1975;51 (Suppl 1):166–170. [PMC free article] [PubMed] [Google Scholar]
  19. VAN DE KAMER J. H., TEN BOKKEL HUININK H., WEYERS H. A. Rapid method for the determination of fat in feces. J Biol Chem. 1949 Jan;177(1):347–355. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES